The human cytomegalovirus-specific ul1 gene encodes a late-phase glycoprotein incorporated in the virion envelope

Journal of Virology

Volumn 86, Issue 8, 2012, Pages 4091-4101

  Shikhagaie, Medya ^a   Mercé Maldonado, Eva ^b   Isern, Elena ^c   Muntasell, Aura ^d   Mar Alba M ^a,d,e   López Botet, Miguel ^a,d   Hengel, Hartmut ^b   Angulo, Ana ^c  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^d HOSPITAL DEL MAR   (Spain)

^e INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CELL MARKER; HEMAGGLUTININ; VIRUS GLYCOPROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; FIBROBLAST CULTURE; GENE CLUSTER; GENE DELETION; GENE DUPLICATION; GENE EXPRESSION REGULATION; GENE LOCATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN STRUCTURE; LIGAND BINDING; LONG UNIQUE 1 GENE; MOLECULAR EVOLUTION; MOLECULAR RECOGNITION; NONHUMAN; NORTHERN BLOTTING; OPEN READING FRAME; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; TRANS GOLGI NETWORK; VIRAL TROPISM; VIRION; VIRUS ASSEMBLY; VIRUS ENVELOPE; VIRUS GENE; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS STRAIN;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CAPSID PROTEINS; CELL LINE; CYTOMEGALOVIRUS; EVOLUTION, MOLECULAR; GENE DELETION; GENE EXPRESSION REGULATION, VIRAL; GENE ORDER; GENES, VIRAL; GLYCOPROTEINS; HUMANS; KINETICS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN TRANSPORT; SEQUENCE ALIGNMENT; TRANSCRIPTION, GENETIC; VIRAL ENVELOPE PROTEINS; VIRION; VIRUS ASSEMBLY; VIRUS REPLICATION;

HUMAN HERPESVIRUS 5; PONGINE HERPESVIRUS 4;

EID: 84861362796     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06291-11     Document Type: Article

References (61)

1. Alba MM, Das R, Orengo CA, Kellam P. 2001. Genomewide function conservation and phylogeny in the Herpesviridae. Genome Res. 11:43-54.
2. Altschul SF, et al. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.
3. Atalay R, et al. 2002. Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs. J. Virol. 76:8596-8608.
4. Baldick CJ, Jr, Shenk T. 1996. Proteins associated with purified human cytomegalovirus particles. J. Virol. 70:6097-6105.
5. Boehme KW, Guerrero M, Compton T. 2006. Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. J. Immunol. 177:7094-7102.
6. Borst EM, Hahn G, Koszinowski UH, Messerle M. 1999. Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: a new approach for construction of HCMV mutants. J. Virol. 73:8320-8329.
7. Boulton IC, Gray-Owen SD. 2002. Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytes. Nat. Immunol. 3:229-236.
8. Britt B. 2007. CMV maturation and egress, p 311-323. In Arvin A, et al (ed), Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge, United Kingdom.
9. Britt WJ, Vugler LG. 1992. Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116). J. Virol. 66: 6747-6754.
10. Cepeda V, Esteban M, Fraile-Ramos A. 2010. Human cytomegalovirus final envelopment on membranes containing both trans-Golgi network and endosomal markers. Cell. Microbiol. 12:386-404.
11. Cha TA, et al. 1996. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J. Virol. 70:78-83.
12. Chang CP, Vesole DH, Nelson J, Oldstone MB, Stinski MF. 1989. Identification and expression of a human cytomegalovirus early glycoprotein. J. Virol. 63:3330-3337.
13. Chee MS, et al. 1990. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154:125-169.
14. Davison AJ, et al. 2003. Homology between the human cytomegalovirus RL11 gene family and human adenovirus E3 genes. J. Gen. Virol. 84:657-663.
15. Davison AJ, et al. 2003. The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome. J. Gen. Virol. 84:17-28.
16. Dolan A, et al. 2004. Genetic content of wild-type human cytomegalovirus. J. Gen. Virol. 85:1301-1312.
17. Dunn W, et al. 2003. Functional profiling of a human cytomegalovirus genome. Proc. Natl. Acad. Sci. U. S. A. 100:14223-14228.
18. Dveksler GS, et al. 1991. Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV. J. Virol. 65:6881-6891.
19. Eddy SR. 1998. Profile hidden Markov models. Bioinformatics 14:755-763.
20. Elde NC, Malik HS. 2009. The evolutionary conundrum of pathogen mimicry. Nat. Rev. Microbiol. 7:787-797.
21. Engel P, et al. 2011. Human cytomegalovirus UL7, a homologue of the SLAM-family receptor CD229, impairs cytokine production. Immunol. Cell Biol. 89:753-766.
22. Felsenstein J. 1989. Mathematics vs. evolution: mathematical evolutionary theory. Science 246:941-942.
23. Finn RD, et al. 2010. The Pfam protein families database. Nucleic Acids Res. 38:D211-D222.
24. Fraile-Ramos A, et al. 2002. Localization of HCMV UL33 and US27 in endocytic compartments and viral membranes. Traffic 3:218-232.
25. Gupta R, Brunak S. 2002. Prediction of glycosylation across the human proteome and the correlation to protein function. Pac. Symp. Biocomput. 310-322.
26. Hitomi S, et al. 1997. Human cytomegalovirus open reading frame UL11 encodes a highly polymorphic protein expressed on the infected cell surface. Arch. Virol. 142:1407-1427.
27. Holzerlandt R, Orengo C, Kellam P, Alba MM. 2002. Identification of new herpesvirus gene homologs in the human genome. Genome Res. 12: 1739-1748.
28. Hubbard TJ, et al. 2007. Ensembl 2007. Nucleic Acids Res. 35:D610-D617.
29. Huber MT, Compton T. 1998. The human cytomegalovirus UL74 gene encodes the third component of the glycoprotein H-glycoprotein L-containing envelope complex. J. Virol. 72:8191-8197.
30. Kammerer R, Zimmermann W. 2010. Coevolution of activating and inhibitory receptors within mammalian carcinoembryonic antigen families. BMC Biol. 8:12.
31. Kohler CP, et al. 1994. Use of recombinant virus to assess human cytomegalovirus early and late promoters in the context of the viral genome. J. Virol. 68:6589-6597.
32. Kuespert K, Pils S, Hauck CR. 2006. CEACAMs: their role in physiology and pathophysiology. Curr. Opin. Cell Biol. 18:565-571.
33. Lilley BN, Ploegh HL, Tirabassi RS. 2001. Human cytomegalovirus open reading frame TRL11/IRL11 encodes an immunoglobulin G Fc-binding protein. J. Virol. 75:11218-11221.
34. Margulies BJ, Browne H, Gibson W. 1996. Identification of the human cytomegalovirus G protein-coupled receptor homologue encoded by UL33 in infected cells and enveloped virus particles. Virology 225:111-125.
35. Mocarski ES, Courcelle CT. 2001. Cytomegaloviruses and their replication, p 2629-2673. In Knipe DM, et al (ed), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
36. Murphy E, et al. 2003. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc. Natl. Acad. Sci. U. S. A. 100:14976-14981.
37. Nielsen H, Engelbrecht J, Brunak S, von Heijne G. 1997. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng. 10:1-6.
38. Patrone M, et al. 2005. Human cytomegalovirus UL130 protein promotes endothelial cell infection through a producer cell modification of the virion. J. Virol. 79:8361-8373.
39. Pötzsch S, et al. 2011. B cell repertoire analysis identifies new antigenic domains on glycoprotein B of human cytomegalovirus which are target of neutralizing antibodies. PLoS Pathog. 7:e1002172.
40. Pruitt KD, Tatusova T, Klimke W, Maglott DR. 2009. NCBI reference sequences: current status, policy and new initiatives. Nucleic Acids Res. 37:D32-D36.
41. Quinnan GV, Jr, et al. 1984. Comparative virulence and immunogenicity of the Towne strain and a nonattenuated strain of cytomegalovirus. Ann. Intern. Med. 101:478-483.
42. Ripalti A, Mocarski ES. 1991. The products of human cytomegalovirus genes UL1-UL7, including gp48, are dispensable for growth in cell culture, p 57-62. In Landini MP (ed), Progress in cytomegalovirus research: proceedings of the Third International Cytomegalovirus Workshop. Elsevier, Amsterdam, Netherlands.
43. Ryckman BJ, et al. 2008. Characterization of the human cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells. J. Virol. 82:60-70.
44. Sanchez V, Angeletti PC, Engler JA, Britt WJ. 1998. Localization of human cytomegalovirus structural proteins to the nuclear matrix of infected human fibroblasts. J. Virol. 72:3321-3329.
45. Sanchez V, Greis KD, Sztul E, Britt WJ. 2000. Accumulation of virion tegument and envelope proteins in a stable cytoplasmic compartment during human cytomegalovirus replication: characterization of a potential site of virus assembly. J. Virol. 74:975-986.
46. Sanchez V, Sztul E, Britt WJ. 2000. Human cytomegalovirus pp28 (UL99) localizes to a cytoplasmic compartment which overlaps the endoplasmic reticulum-Golgi-intermediate compartment. J. Virol. 74:3842-3851.
47. Sekulin K, Gorzer I, Heiss-Czedik D, Puchhammer-Stockl E. 2007. Analysis of the variability of CMV strains in the RL11D domain of the RL11 multigene family. Virus Genes 35:577-583.
48. Sinzger C, et al. 2008. Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40/E. J. Gen. Virol. 89:359-368.
49. Sinzger C, et al. 1999. Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome. J. Gen. Virol. 80(Pt 11):2867-2877.
50. Slevogt H, et al. 2008. CEACAM1 inhibits Toll-like receptor 2-triggered antibacterial responses of human pulmonary epithelial cells. Nat. Immunol. 9:1270-1278.
51. Spaderna S, Blessing H, Bogner E, Britt W, Mach M. 2002. Identification of glycoprotein gpTRL10 as a structural component of human cytomegalovirus. J. Virol. 76:1450-1460.
52. Spaderna S, et al. 2005. Deletion of gpUL132, a structural component of human cytomegalovirus, results in impaired virus replication in fibroblasts. J. Virol. 79:11837-11847.
53. Stanton RJ, et al. 2010. Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication. J. Clin. Invest. 120:3191-3208.
54. Talbot P, Almeida JD. 1977. Human cytomegalovirus: purification of enveloped virions and dense bodies. J. Gen. Virol. 36:345-349.
55. Tan K, et al. 2002. Crystal structure of murine sCEACAM1a[1,4]: a coronavirus receptor in the CEA family. EMBO J. 21:2076-2086.
56. Thompson JD, Gibson TJ, Higgins DG. 2002. Multiple sequence alignment using ClustalW and ClustalX. Curr. Protoc. Bioinformatics 2:2.3.
57. Varnum SM, et al. 2004. Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J. Virol. 78:10960-10966.
58. Wagner M, Gutermann A, Podlech J, Reddehase MJ, Koszinowski UH. 2002. Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus. J. Exp. Med. 196:805-816.
59. Wang D, Shenk T. 2005. Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. Proc. Natl. Acad. Sci. U. S. A. 102:18153-18158.
60. Yao F, Courtney RJ. 1992. Association of ICP0 but not ICP27 with purified virions of herpes simplex virus type 1. J. Virol. 66:2709-2716.
61. Yu D, Smith GA, Enquist LW, Shenk T. 2002. Construction of a selfexcisable bacterial artificial chromosome containing the human cytomegalovirus genome and mutagenesis of the diploid TRL/IRL13 gene. J. Virol. 76:2316-2328.